02/14/2025
3:44 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
3:07 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
3:45 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form DEF 14A | |
01/22/2025
3:02 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
| Form SCHEDULE 13D | |
01/13/2025
3:08 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
3:14 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
5:00 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form PRE 14A | |
01/08/2025
3:15 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
| Form SCHEDULE 13G | |
01/07/2025
3:05 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
5:04 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B5 | |
01/06/2025
8:00 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AEON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AEON Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
01/06/2025
5:00 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B5 | |
11/13/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:07 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:08 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B3 | |
10/07/2024
4:01 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4/A | |
09/04/2024
8:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:53 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:59 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form EFFECT | |
08/12/2024
3:20 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B3 | |
08/12/2024
3:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K/A | |
08/05/2024
11:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form EFFECT | |
07/29/2024
3:11 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Grodnensky Oleg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:43 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
07/09/2024
7:06 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:02 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
3:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:09 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:07 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
8:05 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K/A | |
05/14/2024
8:14 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
05/14/2024
8:15 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form ARS/A | |
05/03/2024
6:01 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:18 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
04/18/2024
5:22 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Park Seongsoo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4/A | |
04/12/2024
6:00 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:07 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
04/01/2024
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:16 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
2:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q/A | |
03/29/2024
2:49 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
2:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
5:39 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:43 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:45 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:46 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:48 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
